The majority of standard blood-based tests performed in veterinary medicine measure an analyte that is readily detectable in blood using a simple biochemical measure (e.g. to test blood glucose, glucose reacts with glucose oxidase on a test strip and the reaction is read by the glucometer). OncoK9 is a completely different type of test which targets fragile cell-free DNA (cfDNA) in the blood that requires special handling and processing. Because the test involves sequencing large portions of the patient’s genetic code, or genome, it takes many days to prepare the sample, carry out the sequencing and subsequent bioinformatic analyses, and prepare the results for reporting. For additional perspective, the OncoK9 test generates billions of data points for each subject, unlike any other test available today for veterinary use.